While the increase in price target could be seen as a positive signal, the reaffirmation of the Underweight rating suggests that Morgan Stanley's outlook on VCTR remains cautious. The mixed message may lead to a neutral short-term impact on the stock as the market digests both the positive and negative aspects of the analyst's view.